A carregar...
Overcoming endocrine resistance in metastatic breast cancer: Current evidence and future directions
About 75% of all breast cancers are estrogen receptor (ER)-positive. They generally have a more favorable clinical behavior, prognosis, and pattern of recurrence, and endocrine therapy forms the backbone of treatment. Anti-estrogens (such as tamoxifen and fulvestrant) and aromatase inhibitors (such...
Na minha lista:
| Publicado no: | World J Clin Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4259959/ https://ncbi.nlm.nih.gov/pubmed/25493235 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v5.i5.990 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|